CURB tested added SBRT for limited progression during systemic treatment. Its lung and breast subgroup findings should not be combined into one rule for every metastatic cancer.
The randomised phase 2 report compared standard care with or without SBRT in 106 participants, including 59 with NSCLC and 47 with breast cancer. Progression-free survival began at randomisation. The overall comparison favoured added SBRT; the prespecified lung subgroup showed a benefit and the breast estimate was imprecise and nonsignificant.
The captured registry lists active, not recruiting status and estimated 2027 completion. That administrative status is distinct from the published 2024 analysis or current availability at a site. It does not make the report a study in every oligoresidual or first-line limited-metastatic setting.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
106 randomised.
| Endpoint | Arm | n | Value | HR (95% CI) | p | Source |
|---|---|---|---|---|---|---|
| Progression-free survival from randomisation, overall 2024 reportprimary | SBRT plus standard care | 55 | 7.2 months | 0.53 (0.35 to 0.81) | 0.0035 | link |
| Standard care | 51 | 3.2 months | ||||
| Progression-free survival, prespecified NSCLC subgroup | SBRT plus standard care | 31 | 10 months | 0.41 (0.22 to 0.75) | 0.0039 | link |
| Standard care | 28 | 2.2 months | ||||
| Progression-free survival, prespecified breast subgroup | SBRT plus standard care | 24 | 4.4 months | 0.78 (0.43 to 1.43) | 0.43 | link |
| Standard care | 23 | 4.2 months |
Shares SBRT / SABR (stereotactic radiotherapy), Breast cancer (all types) and the tags education-audit, local-treatment.
Shares SBRT / SABR (stereotactic radiotherapy), Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Non-small-cell lung cancer and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Mark E. Robson, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/